Bac kground: Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterised by abdominal pain and altered bowel movements. Cognitive behavioural therapy (CBT) has been shown to be effective in reducing symptom severity in IBS and enhancing quality of life/ functioning. The present study sought to identify how CBT achieves change in these outcomes.
Introduction
Irritable bowel syndrome is a functional gastrointestinal disorder characterised by abdominal pain and associated changes in bowel habits [1] . The prevalence of IBS is estimated to be between 10 and 22% in the UK [2, 3] with a similar global prevalence rate [4] . There are no physiological diagnostic markers for IBS and it has long been established as a 'biopsychosocial illness' [5, 6] . As such physiological factors such as genetics or infection interact with psychological and social factors such as unhelpful gastrointestinal (GI) related cognitions, anxiety and life stress to result in bowel symptoms and abdominal pain.
Cognitive behavioural therapy (CBT) has been shown to effectively reduce symptom severity and enhance quality of life in IBS [7] [8] [9] . However, there is not one generic CBT model or approach in IBS. A number of CBT models for IBS have been developed [10] [11] [12] utilising different cognitive and behavioural strategies to target the key mechanisms identified by the respective models. The three system's model for IBS, as based on Lang's three system's model of panic disorder [13] , identifies gastrointestinal (GI) related cognitions and behaviours as key factors in maintaining symptoms [12] .
Therapeutic strategies such as challenging unhelpful thinking patterns and goal setting are used to change cognitions and behaviours. More recently, an interoceptive CBT model of IBS (CBT-IE) has been developed [11] . This model posits that symptoms are maintained by GI specific anxiety and hypervigilance to symptoms [11] . Exposure based techniques (interoceptive and in vivo) are used in CBT-IE to reduce GI specific anxiety and hypervigilance.
Id entifying Treatment Mechanisms
The term 'mechanism' refers to the processes through which treatments have effect on the desired outcome [14] . Understanding what the key mechanisms of treatment are, is important for modifying treatments so that they can more effectively target identified mechanisms of action [15] . This has the potential for improving the efficacy and efficiency of treatments. Insight into mechanisms of change in treatments can also inform the understanding of the nature of IBS. Evidence for key processes in the maintenance of IBS can be inferred from research demonstrating how treatments reduce symptom
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severity through change in specific mechanistic processes [14, 16] . I.e. if treatment works by reducing unhelpful GI cognitions we can infer that these cognitions are likely maintaining factors of IBS.
Both three system's CBT and CBT-IE may be classified as 'endogenous' stress models of IBS [17] . Both identify stress-inducing processes arising specifically from IBS symptoms (e.g. GI specific cognitions, behaviours, anxiety) as key maintaining processes of IBS [17, 18] . In contrast 'exogenous' stress models of IBS postulate that symptom-exacerbating stress arising from factors external to IBS (e.g. stress or general anxiety), are central maintaining factors of IBS [17] . While there is evidence to show that anxiety exogenous to IBS may have a causal role in the onset [19] and that those with IBS have increased stress reactivity [20, 21] , there is less evidence suggesting that changing such exogenous factors precede change in IBS symptoms [16] . A systematic review of treatment mechanisms in CBT for IBS suggested that across different CBT treatment protocols change in IBS-specific processes, particularly GI related cognitions, were key in reducing symptom severity and improving quality of life (QoL) [16] .
Cognitive and behavioural responses have been shown to have a mechanistic role in treatment effect across CBT protocols [17, [22] [23] [24] [25] . In CBT-IE, avoidance was shown to mediate the a reduction of symptom severity [25] . Similarly, the mechanistic role of both GI related cognitions and behaviours was demonstrated in a randomised controlled trial assessing the efficacy of a three system's CBT treatment when added to an antispasmodic versus an antispasmodic alone [22] . The data from this trial is used in the present paper. The trial recruited adults from primary and secondary care sites in South London and assessed outcomes at baseline, 1.5, 3, 6 and 12 months post-randomisation [12] . CBT plus antispasmodic medication were superior to medication alone in reducing symptom severity and improving functioning at 1.5 and 3 months follow-up [12, 26] . There was some waning of response at 6 and 12 months. The trajectories for both outcomes are illustrated in panel A and B in appendix C.
Previous mediation analysis using this data conducted sequential modelling in order to identify whether GI related cognitions or behaviours changed first in a sequence of change from treatment to the outcomes of symptom severity, work and social adjustment and anxiety [22] . Separate models were run for each outcome and GI related behaviours were assessed as one construct that included
both avoidance behaviours (e.g. avoiding foods or situations) and safety behaviours (e.g. checking stools or access to the toilet). Change in behaviour was found to precede change in cognitions for all outcomes. However, the analysis did not include mediators measured at consecutive time points, limiting inferences about causality.
The present study sought to build on the previous study and wider research to explore in more detail the order of change during therapy. Based on the endogenous models of IBS, it is hypothesized that for change in outcomes to occur, it is primarily important for GI related cognitions and behaviours to change. Change in these IBS specific processes is hypothesized to lead to reduction in general anxiety.
In contrast, exogenous models would lead us to expect that general anxiety would change prior to GI related cognitive and behavioural processes, as general anxiety (or stress) is the key target for change in such treatment approaches.
The present analyses advances the analytic strategy used previously by using consecutive time points (from baseline to 12 months) to aid inferences about causality. Although the significant treatment by group effect was lost by 6 months, it has been argued that it is important to conduct mechanistic research in the absence of significant treatment effects. This allows information to be gathered about what may have been responsible for this the lack of sustained effect. For example, whether the treatment did not target the treatment mechanisms as expected [27, 28] . Given that a previous factor analysis found two factors, namely control or safety behaviours and avoidance behaviour were distinguishable, we also wanted to explore these potential mediators separately [29] . The aims of the present study were to (1) identify whether CBT produced change in symptom severity and work and social adjustment via a change in anxiety, cognitions, avoidance behaviours and/or safety behaviours (2) identify whether mediating effects found in cognitions and/or behaviours preceded or were preceded by change in anxiety to produce change in outcomes. 
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The present study is a secondary mediation analysis of an RCT comparing the effect of CBT plus Mebeverine with Mebeverine alone on symptom severity and WSA outcomes [12, 26] . Results indicated that the addition of CBT to mebeverine improved symptom severity and work and social adjustment up to three months after treatment compared to mebeverine alone.
P a rticipants and procedure
Individuals aged between 16 and 50, diagnosed with IBS and meeting the Rome I diagnostic criteria of IBS were recruited from London general practices. A total of 149 participants were randomised to either receive mebeverine alone or to receive CBT in addition to mebeverine [12] . Data of one participant were completely missing, leaving 148 participants for inclusion in the mediation analysis.
CBT treatment
A CBT treatment based on Lang's three systems model [13] was developed for IBS (appendix A). The treatment included psycho-education, cognitive restructuring and behavioural techniques [12] . Psychoeducation provided information about the physiology of the bowel and the brain-gut connection.
Cognitive restructuring was aimed at making individuals aware of unhelpful GI-related thoughts, recognising how these affected their behaviours, and GI symptoms. Behavioural techniques involved goal setting to increase helpful behaviours such as eating regular meals, whilst reducing unhelpful behaviours. These could be avoidance behaviours such as avoiding situations that may be impacted by bowel symptoms, or safety behaviours such as taking precautionary measures like trying to force the bowels to empty before leaving the house. Techniques to manage stress and prevent relapse were also included.
Mea sures Primary Outcomes
The IBS Symptom Severity Scale (IBS-SSS) measures symptom severity specific to IBS, and has been found to be sensitive to change over time [30] . The maximum score is 500, with scores <75 indicating
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normal bowel function. Scores between 75-174 indicate mild IBS, 175-299 moderate IBS and scores between 300-500 indicate severe IBS. The scale has been shown to have good reliability and validity [30] .
The Work and Social Adjustment Scale [31] is a validated measure of work and social adjustment (WSA)/functioning. It contains 5 items each rated 0 -8, with a total potential score of 40. The items assess individuals' ability to engage in day-to-day tasks at work, at home, socially, with family and in relationships. It was found to be a reliable and valid measure of impaired functioning [31] .
Mediators
The Cognitive Scale for Functional Bowel Disorders (CSFBD) [32] is a measure of GI related cognitions.
An example questionnaire item is "my bowel symptoms make me feel out of control". The scale consists of 25 items, with a possible total score of 25 to 175 with higher scores indicating more illness-related cognitions. The measure has been demonstrated to have good reliability and validity [32] .
The Hospital Anxiety and Depression Scale (HADS) [33] is a general measure of depression and anxiety.
Just the anxiety subscale was used to assess general anxiety with items such as "I feel tense or wound up". This is made up of 7 items scored from 0 to 3, with a total possible score of 21. Scores of 8 and above are said to indicate anxiety [34] with good sensitivity (0.9).
The IBS Behavioural Responses Questionnaire (IBS-BRQ) [29] was used to measure GI avoidance behaviour ("I avoid going out in case I have problems with my IBS") and GI safety behaviour ("I spend more time on the toilet than I would ideally like"). Both types of behaviour are asserted to maintain anxiety in the anxiety and health anxiety literature [35] . However, the nature of each behaviour is different. One seeks to exert control over the experience of illness in some way (safety behaviours) and the other relies on withdrawing from certain activities to prevent anticipated troublesome symptoms or experiences (avoidance behaviours).
Sta tistical Analysis General
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The data were standardised by subtracting the mean of the given scale from each score and dividing by the standard deviation for each given time point. Standardising data reduces potential problems of multicollinearity and allows comparison of indirect effects [36] . Using Z scores in mediation has been shown to provide more accuracy in statistical tests and confidence limits, as shown in several stimulation studies [37] .
It has been recommended that mediation variables are assessed for significant change prior to mediation analysis [38] . For anxiety and GI related cognitions, assessment of main effects and interactions were conducted in the previous mediation paper [12, 26] and presented again in this paper only for contextual clarity. Repeated measures ANOVAs were then conducted to assess the main effects of group and time and the interaction (time x group) on the avoidance and safety behavioural subscales of the BRQ, over the three time points included in the mediation analysis (1.5, 3 and 6 months post randomisation). This analysis allowed assessment of whether change in mediator variables occurred over time, between the treatment and control groups. Significant interactions indicate that there was a change over time, which differed between groups
Mediation models
Mediation models were fitted in the structural equation modelling (SEM) framework using Mplus version 7. SEM is advocated as an approach that allows simultaneous modelling of several variables, enabling the investigation of more complex mediation models [27, 39, 40] than would be possible by conducting a series of regressions utilising Baron & Kenny's framework [41] . Path tracing rules [42] akin to what is specified in the mediation literature were used to calculate indirect effects [40] . Biascorrected bootstrap estimates and confidence intervals were calculated for the indirect effects as recommended for the sample size [43] . Full information maximum likelihood was used to handle All mediation models controlled for baseline measures of the mediator and outcome to account for the potential confounding of the non-randomised mediator-outcome relationship, which is widely agreed to be important [40, 45, 46] . Baseline measures of the mediator and outcome are likely to be amongst
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the most important confounders [47, 48] and may also provide adjustment for other related confounders not included in the model. Baseline data collected just prior to randomisation was included in the analysis for all measures, apart from GI avoidance and safety behaviours as these data
were not collected at this timepoint. In these cases, data from when the participants first entered the trial (2 weeks prior to randomisation) was used.
Simple mediation models with single mediators were run first to assess whether the variables identified in the CBT model of IBS significantly mediated treatment effect on outcome (figure 1).
Models were run for each potential mediating variable: anxiety, GI related cognitions, GI avoidant and GI safety behaviours. These were run separately for each outcome also.
Sequential mediation models were then run to further elucidate the relationship between cognitive and behavioural processes and anxiety. Specifically, we sought to understand whether it was necessary for cognitive and behavioural change to occur first, to produce a subsequent reduction in anxiety, ultimately leading to improved outcomes. To assess this, we compared models that had cognitive or behavioural change preceding change in anxiety, to models where change in anxiety preceded cognitive or behavioural change.
To allow for causal interpretations of mediational analyses, it is important to ensure that variables are measured in a plausible temporal sequence [40, 46, 49, 50] . In other words, to infer that treatment causes change in a mediator and that this change causes subsequent change in an outcome, the mediator should be measured at an earlier time point than the outcome. To this end, the simple mediation models included mediators measured at 1.5 months post randomisation and outcomes measured at 12 month post randomisation (figure 1). In sequential mediator models, the first mediator in the sequence was measured at 1.5 months post randomisation and the second mediator at 3 months post randomisation. Outcome measures assessed at 12 month post randomisation were also used as this was the ultimate follow up time point and there was no significant difference between outcomes at 6 months and 12 months post randomisation.
Three types of model fit criteria were used to select the best fitting mediation model. Final models were selected based on whether they had acceptable or good fit across the majority of the three types
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of fit indices (absolute, incremental and information) as has previously been recommended [51] [52] [53] [54] [55] , giving priority to the RMSEA, CFI and TLI. This method was designed to tackle the sometimes conflicting criteria and the issues with model selection uncertainty [55] . Further details of the analysis are contained in appendix B.
Results
P a rticipants
The majority of participants met the Rome I diagnostic criteria for irritable bowel syndrome (85% [12, 26] .
Ch anges in mediating variables: Anxiety, behaviours and cognition
The line graphs in figure 2 depict change in mediator variables over the 3 time points included in the mediation analysis. The changes in anxiety and cognition were previously reported in detail [12, 26] with a summary of the results presented here. There was a significant main effect of group but not time on both anxiety and GI related cognitions, indicating that on average over the different follow-up time points anxiety and GI related cognitions were significantly lower in the CBT group than in the control group (figure 2, panels A and B).
Analysis of the behavioural subscales in the present paper found that there was a significant main effect of group on GI safety behaviours F( 
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difference between the two groups at baseline, with their profile plots crossing between baseline and post treatment (figure 2, panel C). There were significant group*time interaction effects for all four potential mediator variables (all p < 0.010), which was due to the differences in effects between baseline and the two follow-up measurements. 
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Simple mediation models
The four variables of interest as mediators, GI related cognitions, avoidance behaviour, safety behaviour and anxiety were initially studied using simple mediation models.
Simple mediation models, each in turn including anxiety, GI related cognitions and GI safety behaviours, fitted the data well ( Avoidance behaviour did not mediate the effect of treatment on either outcome (table 2). Figure 3 shows the standardized indirect effects with the 95% confidence intervals across the four mediators 
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Sequential Mediation Models Full and partial mediation models
Comparisons of sequences modelled as full or partial mediation models for the outcome of symptom severity showed that full mediation models fit the best for all mediation sequences (appendix E) apart from the sequence R anxiety GI safety behaviours symptom severity (model 8a, table 2), where there was little difference in the fit of the models. Comparisons of full and partial mediation models on the WSA found that all sequences fit better as full mediation models (models 5b to 8b, table 2). While most of the differences seen in AIC and BIC between full and partial models were greater than two units, they were generally small (appendix E). 
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Behaviours and Anxiety
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As avoidance behaviour was not a significant mediator in the basic mediation models, this was not taken forward into a sequential model, and only GI safety behaviours were studied. 
Discussion
Our paper aimed to establish whether illness-related cognitions, avoidance and safety behaviours and anxiety were significant mediators of treatment effect on the outcomes of symptom severity and WSA.
Change in GI related cognitions, GI related safety behaviours and general anxiety were found to mediate the effect of CBT on both outcomes. However, avoidance behaviour was not a significant mediator. The secondary aim of the paper was to elucidate whether GI related cognitive and behavioural change preceded changes in anxiety or vice versa. The results were supporting of endogenous models of IBS, indicating that cognitive and behavioural (safety behaviours) responses specific to IBS changed prior to a reduction in general anxiety. This sequence was found to best explain
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the treatment effect on both outcomes. These results suggest that targeting change in such processes are necessary to reduce both anxiety and consequently symptom severity and impaired WSA.
Mechanisms of Treatment
The results of our basic mediation analyses provided some support for both endogenous and exogenous models of IBS. The finding that GI related cognitions and GI safety behaviours significantly mediated the treatment effect on both outcomes lends support to endogenous models of IBS. This fits with findings from previous mediation studies conducted in CBT trials for IBS, which have demonstrated the mechanistic roles of cognitions, behaviours and GI specific anxiety [16] . However, the finding that general anxiety was also a significant mediator provides some support for exogenous models of IBS. These models identify stress (or anxiety) external to IBS as a key maintaining factor of IBS symptoms and therefore important to change in psychological treatment. Furthermore, it was surprising to find that avoidance behaviour was not a significant mediator. The paths from avoidance behaviour to outcome in the simple mediation models for both outcomes were not significant, suggesting that change in avoidance behaviour was not related to outcome. In contrast, significant paths from randomisation to avoidance behaviour at 1.5 months follow up indicated that CBT, at least initially, reduced avoidance behaviours (table 3) . Such findings suggest that change in avoidance does not result in reductions in symptom severity or enhanced functioning.
A recent study assessing the mediating properties of avoidance behaviour, GI specific anxiety, selfefficacy and non-reactivity in CBT-IE compared to CBT without exposure (CBTWE) [25] could explain this finding. This study found that both avoidance behaviour and GI specific anxiety mediated the additional benefit of CBT-IE compared to CBTWE. It could be that in a treatment protocol that utilises more exposure-based techniques to target GI specific anxiety and hypervigilance, avoidance behaviour has more of a mechanistic role. Furthermore, moderated mediation analysis indicated that the mediated effect of avoidance was larger for participants who had high avoidance at baseline. This too offers an explanation for our results: in the absence of assessing moderated mediation, our analysis may not have detected avoidance behaviour as a mediator for a portion of the sample. Alternatively,
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our overall sample may not have had sufficiently high baseline avoidance for this to be a significant mediator. Other reasons for this finding are considered further under limitations.
Our results demonstrate the importance of GI safety behaviours in the maintenance of symptoms and disruption to work and social functioning in IBS. Safety behaviours, such as excessive straining on the toilet or the use of medications to prevent symptoms, have been shown to disrupt bowel functioning and motility [56, 57] . Furthermore, individuals with IBS have reported that engaging in behaviours such as taking preventative medication and wearing protective underwear has a substantial impact on their daily lives [58, 59] . These results highlight that changing such behaviours is an important component of therapy. While some CBT protocols target a reduction of endogenous stress and focus on changing these symptom-specific behaviours, other protocols focus primarily on reducing exogenous stress and may not target safety behaviours.
The sequential models in both the previous mediation study using this data and the present study demonstrate that a three system's CBT treatment is effective in changing GI related cognitions and safety behaviours. The previous results indicated that behaviour change preceded cognitive change
[22], suggesting behaviour change may facilitate the modification of cognitions. The present results demonstrate that GI specific cognitive and behavioural change precedes reduction in general anxiety.
This fits with previous research in anxiety disorders and health anxiety, which has suggested that targeting the use of safety behaviours is necessary for the reduction of anxiety [35, 60, 61] and improving illness trajectories [62] .
Together, these results provide further support for endogenous models of IBS. As IBS specific responses are shown to be of primary importance for changing outcomes we may consequently infer that these are key maintaining processes in IBS. In contrast, if IBS was primarily maintained by stress/anxiety external to IBS (e.g. general anxiety, life events) we may expect treatment to operate primarily by reducing general anxiety. To better assess the mechanistic value of external (or general) stress/anxiety versus IBS-specific stress (or GI related cognitive, behavioural and affective responses), a parallel mediator model could be used to quantify the mediating effects of each type of mediator.
Limitations
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The present study did not collect a measure of GI specific anxiety, such as that measured by the visceral sensitivity index [63] . Consequently, we were not able to compare the mediating effect of general versus IBS-specific anxiety. The dichotomy between endogenous and exogenous stress in IBS may also be inadequate, as stress can be internal and external to IBS within the same individual.
It is recommended that mediators are measured at least once during treatment [14] . However, assessments in the original trial were only taken post treatment (aside from pre-treatment measures).
Therefore, the mediational change occurred after treatment had finished. The meditational processes following treatment may differ to those that occur during treatment. Furthermore, there is a large time difference between the mediator measured at 1.5 and 3 months and the outcome at 12 months.
Future studies should aim to include measurements at closer intervals for the purpose of assessing mediation [14] as has been conducted in previous mediation studies in IBS [17, 25] .
Our analysis was conducted in the context of a waning treatment effect at the 12 month follow up in order to preserve temporal sequencing of variables [12] . Future mediational studies with similar follow up periods are needed to ascertain whether the results are replicated when the treatment effect is still observed. Nevertheless, assessing mediation in the context of no treatment effect is now widely considered valid and important [45, 46, 64] . It allows us to gather information about where in the theoretical mediation pathway treatment fails. This can help us to refine and improve treatments. The treatment in the present study had a significant effect up until the 3 month follow up. The decline in treatment effect may be attributable to the lack of mechanistic effect found in avoidance behaviour.
This has previously been found to significantly mediate the treatment effect of CBT-IE in IBS [25] .
Although in the present study avoidance behaviour was changed by treatment, it may be that the reduction in such behaviour was not sufficient to sustain the efficacy of the treatment effect at 12 months. It may be that the inclusion of more interoceptive exposure techniques as used in CBT-IE may be beneficial to the long-term effects of treatment by increasing the magnitude of treatment effect on avoidance behaviour reduction.
The final models with best fit were the full mediation models, which may in part be due to the lack of a sustained treatment effect i.e. there were no direct effects of treatment on outcome, yet there were significant indirect effects. It is, however, unlikely that our models included all possible mediators (such as GI specific anxiety). Future analysis would ideally include all hypothesised mediators in a model. Our study was also limited by a relatively small sample size, which may increase the probability of type II error [43] .
Finally, IBS is a heterogeneous population with varying degrees of symptom severity, impairment and psychosocial impact [65, 66] . The two moderated mediation studies conducted to date have indicated that mechanisms of change may differ based on different patient characteristics at baseline [25, 67] .
Our analysis was not designed to assess this and therefore may provide an incomplete picture of treatment mechanisms across the IBS population.
Strengths
The present study used robust methodology to study the mediation effects of CBT in IBS. Unlike other studies reviewed [16] , the inclusion of mediator variables were theoretically informed and assessed at adequate intervals to allow temporal precedence, increasing the plausibility of interpreting effects as causal. Effects of mediator and outcome variables measured at baseline on the mediated effect and outcome were controlled for, to reduce the potential for residual confounding of the non -randomised mediator -outcome relationships in the models. In addition, the mediation analysis was conducted using data from an RCT, which further reduces the potential for confounding factors where the treatment is randomised.
Co nclusion
Our results suggest that CBT treatments for IBS should target change in IBS specific cognitive and behavioural responses to symptoms as these processes lead to reduction in general anxiety and subsequent improvement in symptom severity and adjustment. These findings are in line with endogenous stress models of IBS. However, the results also indicate a mechanistic role of general
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anxiety. Future studies should seek to assess whether this effect remains significant when GI specific anxiety is included in the mediation models. Methodology regarding selection of partial versus full mediation models
Partial versus full mediation
In mediation the total effect of an independent variable (e.g. treatment) on an outcome can be partitioned into the direct effect (path R to O, figure 1) and the indirect effect (paths from R to O via M, figure 1 ). The indirect effect quantifies the extent to which the treatment effect on the outcome is transmitted via the mediator (mediated effect). The direct effect quantifies the remaining direct effect of treatment on the outcome. We use the term full mediation model to describe a model explicitly assuming the direct effect is essentially equal to zero, allowing for no direct pathway between treatment and outcome, and so postulate that the full effect of the outcome is transmitted via the mediating variable (full mediation model, figure  1 ). Models we describe as partial mediation models allow for both direct and indirect pathways (models 1-4 and the partial mediation model, figure 1 ). In this latter type of model, we can assess whether mediation is partial or full; if there is full mediation, the mediated effect will be statistically significant, with a non-significant direct effect.
If the mediated and direct effects are statistically significant, this indicates partial mediation.
Physical sensations (experience of symptoms) Anxiety
Gastrointestinal related behaviours  Straining on toilet  Checking stools  Avoiding foods  Carrying medication Gastrointestinal related cognitions  "Symptoms are too much to handle"  "Can't concentrate due to pain"
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Appendix C A B Trajectory of primary outcomes
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Appendix D Best fitting models as indicated by standardised indirect effect size for symptom severity and work and social adjustment (WSA). Single headed arrows indicate hypothesized relationships between variables with standardized regression coefficients next to each path with 95% confidence intervals in brackets. Not shown in the di agrams for simplicity are the paths indicating the baseline outcome and mediator variables controlled for by including these as predictors for each dependent variable included in the model. 
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